Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

DexCom, Inc. - Common Stock (NQ:DXCM)

61.41 +0.98 (+1.61%)
Streaming Delayed Price Updated: 2:07 PM EST, Nov 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about DexCom, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
DexCom (DXCM) Stock Is Up, What You Need To Know
Shares of medical device company DexCom (NASDAQ:DXCM) jumped 3.7% in the afternoon session after it rebounded from a steep sell-off that was triggered by its long-term revenue growth outlook. The stock... 
Via StockStory
Topics Earnings
These S&P500 stocks have an unusual volume in today's session
Discover the S&P500 stocks that are experiencing unusual trading volume in today's session. Find out more about these stocks below. 
Via Chartmill
Exploring the top movers within the S&P500 index during today's session.
Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
Dexcom Stock Plunges 13% After-Hours As Q3 Margin Pressures Eclipse Record Profit — Retail Sees ‘Buy The Dip’ Setup
Via Stocktwits
Earnings Scheduled For October 30, 2025
 
Via Benzinga
An Overview of DexCom's Earnings
 
Via Benzinga
AI's Power Problem
AIs are hungry and growing more insatiable by the day. Will we be able to sustainably generate the power needed to feed the AI beast? 
Via The Motley Fool
Topics Artificial Intelligence Economy Energy
Fiserv, eBay, And Garmin Are Among Top 10 Large Cap Losers Last Week (Oct. 27-Oct. 31): Are the Others in Your Portfolio?
These ten large-cap stocks led last week's declines, including Fiserv, Alexandria Real Estate, Chipotle, eBay, after weak results and guidance. 
Via Benzinga
Exploring the top movers within the S&P500 index during today's session.
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session. 
Via Chartmill
Discover which S&P500 stocks are making waves on Friday.
Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
Nasdaq 100 Rebounds, Amazon Jumps 10% On Strong Earnings: What's Moving Markets Friday?
Tech stocks edged higher Friday, rebounding from Thursday's 1.5% drop in the Nasdaq 100 as upbeat earnings from mega-cap giants kept the rally momentum alive. 
Via Benzinga
Why DexCom (DXCM) Stock Is Falling Today
Shares of medical device company DexCom (NASDAQ:DXCM) fell 14.8% in the afternoon session after the company reported underwhelming earnings. 
Via StockStory
Topics Artificial Intelligence Economy Government
Why DexCom Stock Is Crashing Today
The diabetes equipment provider had a strong quarter, but next year is looking weaker than expected. 
Via The Motley Fool
Topics Earnings
Gapping S&P500 stocks in Friday's session
Friday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session. 
Via Chartmill
Top S&P500 movers in Friday's pre-market session
The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements. 
Via Chartmill
DXCM Q3 Deep Dive: Margin Pressures Offset Strong Diabetes Access and Product Expansion
Medical device company DexCom (NASDAQ:DXCM) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 21.6% year on year to $1.21 billion. The company expects the full year’s... 
Via StockStory
Dexcom Stock, Down 13%, Haunted By Its 'Surprisingly Cautious' Outlook
Dexcom's solid third-quarter report was overshadowed Friday by its "surprisingly cautious" outlook, and Dexcom stock tumbled. 
Via Investor's Business Daily
Why Amazon Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
These S&P500 stocks are moving in today's after hours session
As the regular session of the US market on Thursday comes to an end, let's delve into the after-hours session and discover the top S&P500 gainers and losers shaping the post-market sentiment. 
Via Chartmill
DexCom Inc (NASDAQ:DXCM) Reports Q3 2025 Earnings Beat Amid Stock Plunge on Guidance Concerns
DexCom Q3 2025 earnings beat estimates, but stock fell due to full-year revenue guidance that missed analyst expectations. 
Via Chartmill
Topics Earnings
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
DexCom (NASDAQ:DXCM) Beats Q3 Sales Expectations But Stock Drops
Medical device company DexCom (NASDAQ:DXCM) announced better-than-expected revenue in Q3 CY2025, with sales up 21.6% year on year to $1.21 billion. The company expects the full year’s revenue to be... 
Via StockStory
What Does the Market Think About DexCom Inc?
 
Via Benzinga
Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday?
Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the mega-caps and the lingering impact of hawkish remarks from Fed Chair Jerome... 
Via Benzinga
Topics Economy
Should You Buy DexCom Stock Before Oct. 31?
The company hasn't had a great year. Is it about to turn things around? 
Via The Motley Fool
Topics Lawsuit
DexCom (DXCM) Reports Earnings Tomorrow: What To Expect
Medical device company DexCom (NASDAQ:DXCM) will be reporting results this Thursday after market close. Here’s what you need to know. 
Via StockStory
DexCom Faces New Reports Of Deaths Linked To G7 Glucose Monitor
Dexcom faces new FDA reports linking its G7 glucose monitor to patient deaths as lawsuits and regulatory scrutiny intensify. 
Via Benzinga
Topics Death Lawsuit
Dexcom Shares Slide After Short Seller Flags 3 Additional Deaths From G7 Devices
Short seller Hunterbrook stated that at least 13 G7 users have died since the device launched in 2023. 
Via Stocktwits
Topics Death Economy
Forecasting The Future: 13 Analyst Projections For DexCom
 
Via Benzinga
2 Stocks Down 17% and 21% to Buy Right Now
Both companies have faced recent challenges, but look likely to overcome them. 
Via The Motley Fool
Topics World Trade
< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.